Sugi Predict

Sugi Predict / Targets / SNRNP200

SNRNP200

U5 small nuclear ribonucleoprotein 200 kDa helicase · O75643 · SNRNP200 on Sugi Atlas →

4,391 patent compounds predicted against SNRNP200, 3,390 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL249928 SCHEMBL249928 0.39 5/20
SCHEMBL2131882 SCHEMBL2131882 0.36 5/20
SCHEMBL2624262 SCHEMBL2624262 0.36 5/20
SCHEMBL13734781 SCHEMBL13734781 0.46 4/20
SCHEMBL3552703 SCHEMBL3552703 0.52 3/20
SCHEMBL1466434 SCHEMBL1466434 0.31 3/20
SCHEMBL3503222 SCHEMBL3503222 0.70 2/20
SCHEMBL3503224 SCHEMBL3503224 0.70 2/20
SCHEMBL3503226 SCHEMBL3503226 0.56 2/20
SCHEMBL12076 SCHEMBL12076 0.55 2/20
SCHEMBL14680194 SCHEMBL14680194 0.49 2/20
SCHEMBL14680225 SCHEMBL14680225 0.49 2/20
SCHEMBL6720997 SCHEMBL6720997 0.48 2/20
SCHEMBL14680180 SCHEMBL14680180 0.42 2/20
SCHEMBL3593079 SCHEMBL3593079 0.41 2/20
SCHEMBL7857534 SCHEMBL7857534 0.34 2/20
SCHEMBL13672422 SCHEMBL13672422 0.34 2/20
Gilteritinib Gilteritinib (SCHEMBL282229) 1.00 1/20
Molibresib Molibresib (SCHEMBL1872390) 1.00 1/20
Molibresib Molibresib (SCHEMBL12671490) 1.00 1/20

Clinical trials — most relevant to SNRNP200 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes PHASE4UNKNOWN
Effects of Exercise Training on Systemic Inflammation an Muscle Repair According to the Obstructive Chronic Pulmonary Disease (COPD) Phenotype PHASE4UNKNOWN
Hormone Replacement Therapy on the Postmenopausal Endometrium PHASE4COMPLETED
Neoadyuvant High-dose of Ifosfamide and Concurrent Radiotherapy in Soft Tissue Sarcoma PHASE2COMPLETED
Safety and Efficacy Study of Small Interfering RNA Molecule (Cand5) to Treat Diabetic Macular Edema PHASE2COMPLETED
A Dose Escalation and Safety Study of I5NP in Patients Undergoing Major Cardiovascular Surgery PHASE1COMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
The Value of circRNAs (hsa_circ_0004001) in Early Diagnosis of HCC nanUNKNOWN
NFC Changes in SLE Patients and Its Correlation With Anti-U1RNPAntibodies and Disease Activity nanUNKNOWN
Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing nanRECRUITING
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Evaluation of the Expression and Prognostic Role of Tumor Stem Cell Marker SOX2 in Odontogenic Cysts and Tumors nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Study of Sperm Molecular Factors Implicated in Male Fertility nanCOMPLETED
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
A Prospective Study of Molecular Detection of Salvageable Early Recurrent Nasopharyngeal Carcinoma After Radiotherapy nanCOMPLETED
Biocollection in MyeloDysplastic Syndrome (P-MDS) nanRECRUITING
Diagnosis of Inflammatory Bowel Disease nanNOT_YET_RECRUITING
Patient's Derived Organoids for Drug Screening in Glioblastoma nanNOT_YET_RECRUITING
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve nanUNKNOWN
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients nanRECRUITING
Identification of Viable Human Embryos Using Three Different Methods nanCOMPLETED
SMN Circular RNAs as Potential Biomarkers for the Therapeutic Response to Nusinersen in Spinal Muscular Atrophy Patients nanUNKNOWN
Emerging Role of NOTCH-related Long Non-coding RNA(s) as Biomarkers in Liquid Biopsy From Colorectal Cancer Patients nanCOMPLETED
Identification of New FTLD Genes nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a SNRNP200 binder may also engage these)

ProteinNameSimilarity
Q6P4T2 — 1.000 Q6P4T2 →
F1LNJ2 — 1.000 F1LNJ2 →
Q9VUV9 — 0.986 Q9VUV9 →
P49135 — 0.980 P49135 →
Q9U2G0 — 0.979 Q9U2G0 →
Q5RA62 — 0.978 Q5RA62 →
P19447 — 0.978 P19447 →
Q1JU68 — 0.977 Q1JU68 →
Q60HG1 — 0.975 Q60HG1 →
Q5ZKK7 — 0.975 Q5ZKK7 →
A2AT37 — 0.974 A2AT37 →
GTF3C3 General transcription factor 3C polypeptide 3 0.974 landscape →
Q0E908 — 0.974 Q0E908 →
Q7KZ85 — 0.974 Q7KZ85 →
MAP4K5 Mitogen-activated protein kinase kinase kinase kinase 5 0.974 landscape →
Q8TAP6 — 0.973 Q8TAP6 →
Q4G005 — 0.972 Q4G005 →
ITPR1 Inositol 1,4,5-trisphosphate-gated calcium channel ITPR1 0.972 landscape →
Q1RMT1 — 0.972 Q1RMT1 →
Q56A27 — 0.972 Q56A27 →
P11881 — 0.971 P11881 →
EIF3A Eukaryotic translation initiation factor 3 subunit A 0.971 landscape →
Q96M32 — 0.971 Q96M32 →
Q6NRD0 — 0.971 Q6NRD0 →
TAF5 Transcription initiation factor TFIID subunit 5 0.971 landscape →
A2VD00 — 0.971 A2VD00 →
Q7ZVK4 — 0.971 Q7ZVK4 →
Q3SZP8 — 0.971 Q3SZP8 →
Q2KJD7 — 0.971 Q2KJD7 →
Q62383 — 0.971 Q62383 →